Creative Life Science Co Documents
Documents
0
Ticker
7837.TWO
ISIN
TW0007837007
Creative Life Science Co SEC Filings
Type | Report | Date |
|---|---|---|
| No documents available | ||
Creative Life Science Co Documents 2026
This page contains all official documents and SEC filings for Creative Life Science Co stock (7837.TWO, ISIN: TW0007837007). This includes annual reports (Form 10-K), quarterly reports (Form 10-Q), and insider transactions (Form 4). Currently 0 documents are available. Data is updated regularly to provide investors with a complete overview of Creative Life Science Co's regulatory filings.
Creative Life Science Co Stock analysis
Creative Life Science Co Creative Life Science Co., Ltd. generates revenue through the sales of its own CMP brand products and agency services for international brands. The CMP product line includes storage and carrying culture medium, sterile transport containers, buffers and diluents, identification reagents, and various culture media types. The company acts as an agent for dry powder culture medium, detection reagents, IVD culture medium, and sampling systems. Its primary market is Taiwan, serving pharmaceutical, biotechnology, food, medical diagnosis, environmental monitoring, and academic research sectors. The company also offers testing, inspection, and certification services to complement its product sales. The firm's revenue streams are derived from direct sales of CMP products to customers in regulated industries such as pharmaceuticals and medical diagnostics. International brand agency sales target similar sectors requiring specialized culture media and diagnostic tools. Testing and certification services are provided to clients needing quality assurance in product development and compliance. All services are concentrated within Taiwan's domestic market, with no mention of international distribution channels. CMP brand products are sold to laboratories and production facilities across multiple industries including food safety testing and environmental monitoring. The agency business focuses on supplying IVD culture media and sampling systems to medical and diagnostic institutions. Testing services support clients in meeting regulatory standards for product safety and efficacy. The company's operations remain strictly within Taiwan, with no indication of global market expansion.